2
3
4
5
6
7
Prins, H. A.B., Zino, L., Svensson, E. M., Verbon, A., de Bree, G. J., Prins, J. M., Reiss, P., Burger, D. M., Rokx, C., Colbers, A.
Veröffentlicht in: Prins , H A B , Zino , L , NOVA Study Team , Svensson , E M , Verbon , A , de Bree , G J , Prins , J M , Reiss , P , Burger , D M , Rokx , C & Colbers , A 2023 , ' Exposure and virologic outcomes of dolutegravir combined with ritonavir boosted darunavir in treatment-naïve individuals enrolled in the Netherlands Cohort Study on Acute HIV infection (NOVA) ' , International Journal of Antimicrobial Agents , vol. 61 , no. 1 , 106697 . https://doi.org/10.1016/j.ijantimicag.2022.106697;
2023
Veröffentlicht in: Prins , H A B , Zino , L , NOVA Study Team , Svensson , E M , Verbon , A , de Bree , G J , Prins , J M , Reiss , P , Burger , D M , Rokx , C & Colbers , A 2023 , ' Exposure and virologic outcomes of dolutegravir combined with ritonavir boosted darunavir in treatment-naïve individuals enrolled in the Netherlands Cohort Study on Acute HIV infection (NOVA) ' , International Journal of Antimicrobial Agents , vol. 61 , no. 1 , 106697 . https://doi.org/10.1016/j.ijantimicag.2022.106697;
2023
8
9
10